|
Bruno Pornel, MD, is President and Chief Scientific Officer at Symfo. He has more than 30 years' experience in the clinical research industry. He participates to the strategic decisions of the company and is involved in its management. With its scientific and regulatory experience he ensures that the solutions proposed to sponsors are adapted and compatible with GCP and ICH regulations.
He has been published widely, has served as a consultant to the pharmaceutical industry and has been a site investigator for over ten years.
He received his MD from the Catholic University of Louvain. He is specialized in gynaecology and obstetrics. | 